What is Neuroelectrics?
Neuroelectrics is at the forefront of personalized brain stimulation therapy, leveraging advanced computational neuroscience to address a spectrum of brain disorders. Their proprietary Starstim platform provides cloud-based, non-invasive neuromodulation solutions, catering to healthcare providers and researchers focused on conditions like epilepsy and depression. The company's commitment to enhancing patient outcomes is evident in its fusion of extensive neuroscience research with tailored treatment protocols, positioning it as a key innovator in the neurotechnology sector.
How much funding has Neuroelectrics raised?
Neuroelectrics has raised a total of $17.5M across 1 funding round:
Series A
$17.5M
Series A (2021): $17.5M with participation from Morningside Venture Capital
Key Investors in Neuroelectrics
Morningside Venture Capital
Morningside Venture Capital is a prominent venture capital firm with a history of investing in early-stage technology companies, likely bringing strategic guidance and capital to Neuroelectrics' growth.
What's next for Neuroelectrics?
The enterprise-level funding context suggests Neuroelectrics is in a significant growth phase, likely focused on scaling its operations, expanding its research and development capabilities, and potentially broadening its market reach. This strategic investment will likely fuel further innovation in their neuromodulation technologies and accelerate the clinical validation and adoption of their personalized brain stimulation therapies, aiming to solidify their position as a leader in treating neurological and psychiatric conditions.
See full Neuroelectrics company page
